Kathryn Gill, McGill University

Research

Anxiety And Mood Disorders Clinical Trials Community Partnerships Comorbidity Dual Diagnosis Family Interventions Knowledge Translation Primary Care

Latest papers

Utilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependence.
Neuropsychiatric disease and treatment · 2014 · senior author
Update on the clinical use of buprenorphine: in opioid-related disorders.
Canadian family physician Medecin de famille canadien · 2012 · senior author
Alterations in brain serotonin synthesis in male alcoholics measured using positron emission tomography.
Alcoholism, clinical and experimental research · 2009 · senior author

All 5 publications

Latest funding

CIHR Team - The Treatment of Comorbid Substance Dependence and Mental Illness
CIHR · 2013 · Nominated PI
$45,136
Illicit and Prescription Opiate Abuse: Understanding Treatment Failure and Improving Outcomes
CIHR · 2011 · Nominated PI
$150,055
The Role of the DCC Gene in Drug Dependence
CIHR · 2011 · Nominated PI
$269,887

All 8 grants and awards

5 publications.

01

Utilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependence.

Mauger S, Fraser R, Gill K

Neuropsychiatric disease and treatment2014Senior author

DOI: 10.2147/ndt.s39692 PMID: 24741316

02

Update on the clinical use of buprenorphine: in opioid-related disorders.

Ducharme S, Fraser R, Gill K

Canadian family physician Medecin de famille canadien2012Senior author

PMID: 22267618

03

Alterations in brain serotonin synthesis in male alcoholics measured using positron emission tomography.

Nishikawa M, Diksic M, Sakai Y, Kumano H, Charney D, Palacios-Boix J, Negrete J, Gill K

Alcoholism, clinical and experimental research2009Senior author

DOI: 10.1111/j.1530-0277.2008.00820.x PMID: 18976348

04

A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.

Margolese HC, Carlos Negrete J, Tempier R, Gill K

Schizophrenia research2006Senior author

DOI: 10.1016/j.schres.2005.11.019 PMID: 16460917

05

Genetic analysis of alcohol intake in recombinant inbred and congenic strains derived from A/J and C57BL/6J progenitors.

Gill K, Boyle AE

Mammalian genome : official journal of the International Mammalian Genome Society2005First author

DOI: 10.1007/s00335-004-2239-x PMID: 16104380

CIHR Team - The Treatment of Comorbid Substance Dependence and Mental Illness

Nominated PICIHR2013Canadian Research Initiative in Substance Misuse

Principal investigators: Gill, Kathryn J; Gauthier, Gail; Beauclair, Linda; Laporte, Lise; Low, Nancy C

Keywords: Anxiety And Mood Disorders; Clinical Trials; Community Partnerships; Comorbidity; Dual Diagnosis; Family Interventions; Knowledge Translation; Primary Care; Substance Dependence; Treatment Outcome

$45,136

Illicit and Prescription Opiate Abuse: Understanding Treatment Failure and Improving Outcomes

Nominated PICIHR2011Operating Grant

Principal investigators: Gill, Kathryn J

Keywords: Allodynia; Detoxification; Heroin; Hyperalgesia; Opiate Abuse; Pain Sensitivity; Personality Disorders; Prescription Opioids; Substance Dependence; Treatment Outcome

$150,055

The Role of the DCC Gene in Drug Dependence

Nominated PICIHR2011Operating Grant

Principal investigators: Gill, Kathryn J

Keywords: Behavioural Genetics; Cocaine Iv Self-Administration; Dcc; Drug Reward; Gene Expression; Gene Mapping; Protein Expression; Psychopharmacology; Quantitative Trait Loci; Substance Dependence

$269,887

CIHR Team in Substance Abuse Treatment

Nominated PICIHR2008Team Grant: Substance Abuse Prevention and Treatment

Principal investigators: Gill, Kathryn J

Keywords: Brief Interventions; Knowledge Transfer; Mental Illness; Primary Care; Program Evaluation; Substance Dependence

$738,055

Multi-System Neuroimaging Studies of Co-Morbid Addiction & Mental Illness

Principal investigatorCIHR2008Emerging Team Grant: Co-morbidity of brain disorders & other health problems-LOI

Principal investigators: Leyton, Marco; Gill, Kathryn J

Keywords: Co-Morbid Mental Illness; Depression; Magnetic Resonance Imaging; Personality Disorders; Positron Emission Tomograph; Substance Dependence

$4,800

The genetic vulnerability to substance abuse: behavioural and linkage analyses

Nominated PICIHR2008Operating Grant - PA: Prevention and Treatment of Illicit Drug Use

Principal investigators: Gill, Kathryn J

Keywords: Alcohol; Cocaine; Drug Sensitivity; Genetic Mapping; Nicotine; Psychopharmacology; Qtl Mapping; Substance Dependence

$100,000

Social support: defining and reinforcing its role in adult substance abuse treatment

Co-investigatorSSHRC1996Standard Research Grants

Principal investigators: Dobkin, Patricia

Keywords: social support; addiction; stress; treatment

$20,000

Behavioral genetic and biochemical studies on the regulation of alcohol intake in mice

Principal investigatorNSERC1993Discovery Grants Program - Individual

Principal investigators: Gill, Kathryn

$60,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Simon Ducharme

Faculty

1 shared papers, latest 2012

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Anxiety And Mood Disorders Dear Professor Gill, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Utilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependence." (2014), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]